Loading...
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
PURPOSE: Prior reports have indicated that patients with colon cancer who demonstrate high-level microsatellite instability (MSI-H) or defective DNA mismatch repair (dMMR) have improved survival and receive no benefit from fluorouracil (FU) -based adjuvant therapy compared with patients who have mic...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2903323/ https://ncbi.nlm.nih.gov/pubmed/20498393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1825 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|